RDEA119

DRUG2 trials

Sponsors

Bayer

Conditions

Advanced Cancer

Phase 1

Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients

CompletedNCT00610194

BayerAdvanced Cancer

Start: 2007-11-28End: 2012-08-01Updated: 2023-10-18

RDEA119 and Sorafenib Combination Dose Escalation Study

CompletedNCT00785226

BayerAdvanced Cancer

Start: 2008-11-30End: 2012-04-30Updated: 2016-10-17